排序方式:
    總頁 1 
      Go

    1.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (vol 15, pg 1031, 2021)

    Lau, G, Yu, ML, Wong     More...

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2022, Volume 16, Issue 2, Pages 486-487

    收錄情况: WOS SCOPUS

    2022影響因子:  6.6  发表年影響因子:  6.6 

    2.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

    Lau, G, Yu, ML, Wong     More...

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2021, Volume 15, Issue 5, Pages 1031-1048

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 36  2022影響因子:  6.6  发表年影響因子:  9.046 

    3.Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation

    Liu, HL, He, X, Wang     More...

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2020, Volume 14, Issue 4, Pages 432-436

    收錄情况: WOS SCOPUS

    2022影響因子:  6.6  发表年影響因子:  6.047 

    4.Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations

    Lau, G, Sharma, M

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2020, Volume 14, Issue 4, Pages 415-428

    收錄情况: WOS SCOPUS

    2022影響因子:  6.6  发表年影響因子:  6.047 

    5.Effect of COVID-19 on patients with compensated chronic liver diseases

    Ji, D, Zhang, DW, Ya     More...

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2020, Volume 14, Issue 5, Pages 701-710

    收錄情况: WOS SCOPUS

    2022影響因子:  6.6  发表年影響因子:  6.047 

    顯示      條  合計   5   條
      總頁 1 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫